
Despite debate about resources and personal burden, studies show that screening significantly reduces mortality.
AI-generated summary
Mammography is offered to Swedish women between the ages of 40 and 74 every 18 to 24 months. The program aims at early detection of breast cancer to improve the chances of survival.
When Lena Nyström was 65, she missed an appointment for a mammogram, she tells DN. Later it turned out that she had again suffered from breast cancer. In both breasts, to top it all off.
Lena Nyström is not alone. Every year around 8,000 Swedish women are affected by breast cancer, which makes it the most common form of cancer among women. The disease is serious. Each year around 1,300 women die from their cancer. In addition, a diagnosis almost always means great physical and psychological suffering. On the other hand. Ten years after the diagnosis, almost nine out of ten sufferers are still alive. Despite the seriousness, the race is not over, far from it. Today, Lena Nyström, who turned 76 years old, has been declared healthy.
One reason for the good survival figures is that a large part of the breast cancer that affects Swedish women is detected early. Because just like with any other cancer, the motto "the earlier, the better" applies. One way to find breast cancer early is with the help of mammography, an X-ray examination of the breasts. Today, all Swedish women aged 40 to 74 are offered mammography every 18 to 24 months.
However, calling hundreds of thousands of women for regular mammography is a very large and resource-demanding device. A legitimate question is therefore whether the screening program provides enough "bang for the buck" to make it worthwhile. Not only in terms of resources, but also personally. The women who choose to participate have a right to expect that they have something to gain from letting an X-ray machine gradually flatten their breasts, and that they are not doing it unnecessarily, including the anxiety that every cancer screening brings.
The benefit of the screening program has been widely debated. In an evaluation from 2022, however, the National Board of Health and Welfare stated that the screening program reduces mortality from breast cancer by 16 percent in the age group 40 to 49 years, and by just over 20 percent in the older age groups. One in five deaths, in other words.
And in a study from 2025, researchers at the Karolinska Institute showed that women who skip their first mammography examination are often less likely to participate in future examinations. These women do not run a greater risk of developing cancer than others, but if they do, they have a clearly increased risk of dying from their disease. The study also showed that a whopping 32 percent of all women who were called to their first screening chose not to.
Charlize, who openly shared her battle against the aggressive blood cancer AML on social media, has died. After undergoing a stem cell transplant and chemotherapy, she was told in October that no further treatment was available.

Two people who traveled through Uganda's international airport have been confirmed with Ebola. Authorities are now investigating whether an interaction at the airport is behind the spread of the infection that has reached Nigeria and Kenya, which is creating concerns about further spread.
The Inspectorate for Care and Care (IVO) has been commissioned by the government to review the specialized eating disorder care in Sweden. The organization Frisk & Fri welcomes the decision and highlights problems with long queues and regional differences.
When a 12-year-old girl in the Stockholm area suffered from an eating disorder, the family faced long waiting times and a heavy responsibility for treatment. Today, the daughter is healthy and mother Nina emphasizes the importance of openness and early support.

A new report from the Swedish Medical Products Agency and the National Board of Health and Welfare identifies four critical areas in healthcare with high vulnerability. Authorities emphasize the need for increased inventories of inputs and finished products to deal with disruptions in global supply chains.

Johan Pettersson, 55, died after receiving the wrong medicine during heart surgery at New Karolinska Hospital in August 2024. Instead of potassium chloride, he was given calcium chloride, which killed the heart muscle. Both he and another patient suffered the same error. The family demands that the truth come out and that similar mistakes never happen again.